Consolidated Statements of Income (Loss) - USD ($) $ in Millions	12 Months Ended
Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 5,045.2	$ 4,642.1	$ 4,609.8
Costs and Expenses
Costs of sales and services	2,873.5	2,590.1	2,526.2
Gross Margin	2,171.7	2,052.0	2,083.6
Selling, general and administrative expenses	714.1	729.7	792.9
Research and development expenses	304.7	287.9	298.1
Restructuring and other charges (income)	108.0	132.2	171.0
Total costs and expenses	4,000.3	3,739.9	3,788.2
Income from continuing operations, non-operating pension and postretirement charges (income), interest expense, net and income taxes	1,044.9	902.2	821.6
Non-operating pension and postretirement charges (income)	20.0	21.2	8.1
Interest income	0.0	(0.1)	(1.9)
Interest expense	131.1	151.3	160.4
Income (loss) from continuing operations before income taxes	893.8	729.8	655.0
Provision (benefit) for income taxes	91.6	150.9	111.5
Income (loss) from continuing operations	802.2	578.9	543.5
Discontinued operations, net of income taxes	(68.2)	(28.3)	(63.3)
Net income (loss)	734.0	550.6	480.2
Less: Net income (loss) attributable to noncontrolling interests	(2.5)	(0.9)	2.8
Net income (loss) attributable to FMC stockholders	736.5	551.5	477.4
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes	804.7	579.8	540.7
Discontinued operations, net of income taxes	(68.2)	(28.3)	(63.3)
Net income (loss) attributable to FMC stockholders	$ 736.5	$ 551.5	$ 477.4
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations (in dollars per share)	$ 6.25	$ 4.46	$ 4.12
Discontinued operations (in dollars per share)	(0.53)	(0.22)	(0.48)
Net income (loss) attributable to FMC stockholders (in dollars per share)	5.72	4.24	3.64
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations (in dollars per share)	6.23	4.44	4.10
Discontinued operations (in dollars per share)	(0.53)	(0.22)	(0.48)
Net income (loss) attributable to FMC stockholders (in dollars per share)	$ 5.70	$ 4.22	$ 3.62

The aggregate amount provided for estimating restructuring charges, remediation costs, gains on sale of assets, in process research and development acquired as part of an asset acquisition, asset impairment losses and other miscellaneous charges to income during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items).

No definition available.